
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.250 | 0.250 | 0.000 |
Shares | 99.750 | 99.750 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.052 | 19.612 |
Price to Book | 3.065 | 3.879 |
Price to Sales | 2.564 | 2.226 |
Price to Cash Flow | 9.858 | 14.682 |
Dividend Yield | 3.039 | 1.491 |
5 Years Earnings Growth | 5.015 | 10.048 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.85 | 103.98 | +0.06% | |
AstraZeneca | GB0009895292 | 7.53 | 12,090.0 | -0.80% | |
Roche Holding Participation | CH0012032048 | 7.47 | 274.20 | -0.54% | |
J&J | US4781601046 | 7.45 | 178.43 | -0.18% | |
Merck&Co | US58933Y1055 | 5.24 | 84.71 | +0.79% | |
Bayer | DE000BAY0017 | 4.62 | 28.16 | -1.47% | |
Gilead | US3755581036 | 4.08 | 115.05 | +2.02% | |
GSK plc | GB00BN7SWP63 | 3.72 | 1,476.00 | +0.48% | |
Chugai Pharmaceutical | JP3519400000 | 3.65 | 6,682.0 | +1.01% | |
Amgen | US0311621009 | 3.64 | 283.64 | +1.26% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 680.32M | -5.39 | 4.00 | 9.13 | ||
Seligson & Co Global Top 25 Brands | 680.32M | -5.38 | 4.01 | 9.09 | ||
FI4000283031 | 652.52M | -2.46 | 15.23 | - | ||
Seligson North American B | 591.3M | 1.16 | 15.01 | 13.33 | ||
Seligson & Co North American A | 591.3M | 0.41 | 14.73 | 13.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review